The primary agenda of the meeting is to consider and approve the un-audited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026.
The Company reiterates that the trading window for dealing in the securities of the Company by Designated Persons and their immediate relatives, pursuant to the Company's Code of Conduct and Fair Disclosure for Prohibition of Insider Trading, remains closed. This closure period began on October 01, 2026, as previously intimated via letter dated September 30, 2026, and will continue until 48 hours after the declaration of the financial results for the quarter and half year ended September 30, 2026.